There are many reasons that a breast biopsy could be inconclusive. This could be because the amount of tissue that was obtained was not sufficient to reach a conclusion (for example, if you had a needle biopsy, this can sometimes happen).lternatively, it could be because the tissue had some abnormalities or irregularities in it that were of unclear significance. Your doctor will work closely with the pathologist who examined the biopsy sample and also potentially with a surgeon to determine what the next step is.
PRALUENT is to be used in the following two groups of patients: 1) patients with an inherited condition called heterozygous familial hypercholesterolemia (HeFH) or 2) patients who have had complications of having too much cholesterol, such as heart attacks and strokes.
March 1, 2011 -- The FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD), a lung disorder that makes breathing difficult. The drug, roflumilast -- carrying the trade name Daliresp -- will be sold in pill form, unlike some other medications for COPD, which are inhaled. The FDA says roflumilast, a new drug class for COPD treatment, is an inhibitor of an enzyme called phosphodiesterase type 4 (PDE-4). The pill is recommended for people with severe COPD associated with chronic bronchitis who have had flares. Roflumilast has been shown to reduce the risk of COPD flares in this group.